WO2002100437A3 - Ophthalmic compositions comprising hyaluronic acid - Google Patents
Ophthalmic compositions comprising hyaluronic acid Download PDFInfo
- Publication number
- WO2002100437A3 WO2002100437A3 PCT/EP2002/006279 EP0206279W WO02100437A3 WO 2002100437 A3 WO2002100437 A3 WO 2002100437A3 EP 0206279 W EP0206279 W EP 0206279W WO 02100437 A3 WO02100437 A3 WO 02100437A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hyaluronic acid
- ophthalmic compositions
- ophthalmic
- compositions
- ketotifen
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR0210139-4A BR0210139A (en) | 2001-06-08 | 2002-06-07 | Pharmaceutical Compositions |
EP02740697A EP1404370A2 (en) | 2001-06-08 | 2002-06-07 | Ophthalmic compositions comprising hyaluronic acid |
AU2002314149A AU2002314149A1 (en) | 2001-06-08 | 2002-06-07 | Ophthalmic compositions comprising hyaluronic acid |
CA002449213A CA2449213A1 (en) | 2001-06-08 | 2002-06-07 | Ophthalmic compositions comprising hyaluronic acid |
JP2003503256A JP2005508866A (en) | 2001-06-08 | 2002-06-07 | Ophthalmic composition comprising hyaluronic acid |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01113959.9 | 2001-06-08 | ||
EP01113958.1 | 2001-06-08 | ||
EP01113958 | 2001-06-08 | ||
EP01113959 | 2001-06-08 | ||
EP01115096.8 | 2001-06-21 | ||
EP01115097.6 | 2001-06-21 | ||
EP01115096 | 2001-06-21 | ||
EP01115097 | 2001-06-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002100437A2 WO2002100437A2 (en) | 2002-12-19 |
WO2002100437A3 true WO2002100437A3 (en) | 2003-04-24 |
Family
ID=27440131
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2002/006279 WO2002100437A2 (en) | 2001-06-08 | 2002-06-07 | Ophthalmic compositions comprising hyaluronic acid |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1404370A2 (en) |
JP (1) | JP2005508866A (en) |
CN (1) | CN1514735A (en) |
AR (1) | AR034371A1 (en) |
AU (1) | AU2002314149A1 (en) |
BR (1) | BR0210139A (en) |
CA (1) | CA2449213A1 (en) |
PE (1) | PE20030206A1 (en) |
WO (1) | WO2002100437A2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8846094B2 (en) | 2003-11-12 | 2014-09-30 | Allergan, Inc. | Peripherally administered viscous formulations |
US8962009B2 (en) | 2004-04-30 | 2015-02-24 | Allergan, Inc. | Sustained release intraocular implants and related methods |
US9265775B2 (en) | 2003-11-12 | 2016-02-23 | Allergan, Inc. | Pharmaceutical compositions |
US9572859B2 (en) | 2004-01-20 | 2017-02-21 | Allergan, Inc. | Compositions and methods for localized therapy of the eye |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002100436A2 (en) * | 2001-06-08 | 2002-12-19 | Novartis Ag | Ophthalmic once-a-day composition |
US8580851B2 (en) | 2002-08-21 | 2013-11-12 | Sucampo Ag | Ophthalmic solution |
JP2004143155A (en) * | 2002-10-01 | 2004-05-20 | Taisho Pharmaceut Co Ltd | Ophthalmic solution |
US20040137079A1 (en) * | 2003-01-08 | 2004-07-15 | Cook James N. | Contact lens and eye drop rewetter compositions and methods |
KR20120005052A (en) * | 2003-08-21 | 2012-01-13 | 수캄포 아게 | Ophthalmic composition |
DE102005035986B4 (en) * | 2005-07-28 | 2009-10-15 | Bausch & Lomb Incorporated | Sterile drippable multiphase emulsifier-free ophthalmic preparation |
US20070077302A1 (en) * | 2005-09-30 | 2007-04-05 | Azaam Alli | Methods for stabilizing ophthalmic compositions |
CN100408046C (en) * | 2005-12-22 | 2008-08-06 | 涂家生 | Macrolide antibiotics sodium hyaluronate eye transfer system |
US7767217B2 (en) * | 2006-03-14 | 2010-08-03 | Foresight Biotherapeutics | Ophthalmic compositions comprising povidone-iodine |
US20090143348A1 (en) * | 2007-11-30 | 2009-06-04 | Ahmet Tezel | Polysaccharide gel compositions and methods for sustained delivery of drugs |
BR112013008186A2 (en) * | 2010-10-04 | 2016-06-21 | Activbiotics Pharma Llc | use of ripazil and analogues to treat eye problems |
KR101412776B1 (en) | 2013-03-11 | 2014-07-01 | 가톨릭대학교 산학협력단 | Eye drop composition for treating keratoconjunctivitis and preparation method of the same |
US10617763B2 (en) | 2013-08-28 | 2020-04-14 | Presbyopia Therapies, LLC | Compositions and methods for the treatment of presbyopia |
US9833441B2 (en) | 2013-08-28 | 2017-12-05 | Presbyopia Therapies Llc | Compositions and methods for the treatment of presbyopia |
US9089562B2 (en) | 2013-08-28 | 2015-07-28 | Presbyopia Therapies Llc | Compositions and methods for the treatment of presbyopia |
US10307408B2 (en) | 2013-08-28 | 2019-06-04 | Presbyopia Therapies, LLC | Contact lens compositions and methods for the treatment of presbyopia |
US9968594B2 (en) | 2013-08-28 | 2018-05-15 | Presbyopia Therapies Llc | Compositions and methods for the treatment of presbyopia |
US11179327B2 (en) | 2013-08-28 | 2021-11-23 | Lenz Therapeutics, Inc. | Compositions and methods for the treatment of presbyopia |
US9320709B2 (en) | 2013-08-28 | 2016-04-26 | Presbyopia Therapies Llc | Storage stable compositions and methods for the treatment of refractive errors of the eye |
US9314427B2 (en) | 2013-08-28 | 2016-04-19 | Presbyopia Therapies Llc | Compositions and methods for the improvement of distance vision and the treatment of refractive errors of the eye |
US10064818B2 (en) | 2013-08-28 | 2018-09-04 | Presbyopia Therapies, LLC | Compositions and methods for the treatment of presbyopia |
US9844537B2 (en) | 2013-08-28 | 2017-12-19 | Presbyopia Therapies Llc | Compositions and methods for the treatment of presbyopia |
PL3500255T3 (en) | 2016-08-19 | 2023-03-13 | Orasis Pharmaceuticals Ltd. | Ophthalmic pharmaceutical compositions and uses relating thereto |
US11648247B1 (en) | 2021-12-16 | 2023-05-16 | Lenz Therapeutics, Inc. | Compositions and methods for the treatment of presbyopia |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0555898A2 (en) * | 1985-04-05 | 1993-08-18 | FIDIA S.p.A. | Medicaments for non-topical use |
RU2089191C1 (en) * | 1994-01-28 | 1997-09-10 | Научно-производственная фирма "Нарт" | Method of prolongation of physiological effect of thymolol with respect to intraocular pressure decreasing |
US5948401A (en) * | 1995-12-22 | 1999-09-07 | Union Carbide Chemicals & Plastics Technology Corporation | Cationic therapeutic systems |
EP0976407A1 (en) * | 1997-05-20 | 2000-02-02 | Senju Pharmaceutical Co., Ltd. | Antiseptic composition |
DE19923829A1 (en) * | 1999-05-17 | 2000-11-23 | Ulrich Kluegel | Complex of hyaluronate, active ingredient and water, useful as topical pharmaceutical or cosmetic composition, is stable and has high content of active agent |
WO2001007049A2 (en) * | 1999-07-23 | 2001-02-01 | Novartis Ag | Ophthalmic composition comprising ketotifen |
-
2002
- 2002-06-06 AR ARP020102106A patent/AR034371A1/en unknown
- 2002-06-07 EP EP02740697A patent/EP1404370A2/en not_active Withdrawn
- 2002-06-07 CA CA002449213A patent/CA2449213A1/en not_active Abandoned
- 2002-06-07 PE PE2002000483A patent/PE20030206A1/en not_active Application Discontinuation
- 2002-06-07 JP JP2003503256A patent/JP2005508866A/en active Pending
- 2002-06-07 BR BR0210139-4A patent/BR0210139A/en not_active Application Discontinuation
- 2002-06-07 WO PCT/EP2002/006279 patent/WO2002100437A2/en not_active Application Discontinuation
- 2002-06-07 AU AU2002314149A patent/AU2002314149A1/en not_active Abandoned
- 2002-06-07 CN CNA028115317A patent/CN1514735A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0555898A2 (en) * | 1985-04-05 | 1993-08-18 | FIDIA S.p.A. | Medicaments for non-topical use |
RU2089191C1 (en) * | 1994-01-28 | 1997-09-10 | Научно-производственная фирма "Нарт" | Method of prolongation of physiological effect of thymolol with respect to intraocular pressure decreasing |
US5948401A (en) * | 1995-12-22 | 1999-09-07 | Union Carbide Chemicals & Plastics Technology Corporation | Cationic therapeutic systems |
EP0976407A1 (en) * | 1997-05-20 | 2000-02-02 | Senju Pharmaceutical Co., Ltd. | Antiseptic composition |
DE19923829A1 (en) * | 1999-05-17 | 2000-11-23 | Ulrich Kluegel | Complex of hyaluronate, active ingredient and water, useful as topical pharmaceutical or cosmetic composition, is stable and has high content of active agent |
WO2001007049A2 (en) * | 1999-07-23 | 2001-02-01 | Novartis Ag | Ophthalmic composition comprising ketotifen |
Non-Patent Citations (5)
Title |
---|
BUCOLO C ET AL: "PHAMACOLOGICAL EVALUATION OF A NEW TIMOLOL/PILOCARPINE FORMULATION", OPHTHALMIC RESEARCH, BASEL, CH, vol. 30, no. 2, March 1998 (1998-03-01), pages 101 - 106, XP001021347 * |
CAMBER O ET AL: "INFLUENCE OF SODIUM HYALURONATE ON THE MEIOTIC EFFECT OF PILOCARPINE IN RABBITS", CURRENT EYE RESEARCH, vol. 6, no. 6, 1987, pages 779 - 784, XP009001244, ISSN: 0271-3683 * |
DATABASE WPI Section Ch Week 199818, Derwent World Patents Index; Class B03, AN 1998-205401, XP002221685 * |
SAETTONE M F ET AL: "EVALUATION OF HIGH-MOLECULAR-WEIGHT AND LOW-MOLECULAR-WEIGHT FRACTIONS OF SODIUM HYALURONATE AND AN IONIC COMPLEX AS ADJUVANTS FOR TOPICAL OPHTHALMIC VEHICLES CONTAINING PILOCARPINE", INTERNATIONAL JOURNAL OF PHARMACEUTICS (AMSTERDAM), vol. 72, no. 2, 1991, pages 131 - 139, XP009001241, ISSN: 0378-5173 * |
UVA M G ET AL: "A NEW ANTI-GLAUCOMA MUCOADHESIVE ASSOCIATION: 0.5% TIMOLOL - 2% PILOCARPINE IN SODIUM HYALURONATE VEHICLE AND ITS IOP LOWERING EFFECTS", INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, ASSOCIATION FOR RESEARCH IN VISION AND, US, vol. 36, no. 4, 14 May 1995 (1995-05-14), pages S735, XP001021354, ISSN: 0146-0404 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8846094B2 (en) | 2003-11-12 | 2014-09-30 | Allergan, Inc. | Peripherally administered viscous formulations |
US9265775B2 (en) | 2003-11-12 | 2016-02-23 | Allergan, Inc. | Pharmaceutical compositions |
US9572859B2 (en) | 2004-01-20 | 2017-02-21 | Allergan, Inc. | Compositions and methods for localized therapy of the eye |
US8962009B2 (en) | 2004-04-30 | 2015-02-24 | Allergan, Inc. | Sustained release intraocular implants and related methods |
Also Published As
Publication number | Publication date |
---|---|
PE20030206A1 (en) | 2003-04-09 |
WO2002100437A2 (en) | 2002-12-19 |
AR034371A1 (en) | 2004-02-18 |
CN1514735A (en) | 2004-07-21 |
CA2449213A1 (en) | 2002-12-19 |
BR0210139A (en) | 2004-06-08 |
JP2005508866A (en) | 2005-04-07 |
AU2002314149A1 (en) | 2002-12-23 |
EP1404370A2 (en) | 2004-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002100437A3 (en) | Ophthalmic compositions comprising hyaluronic acid | |
IL154888A0 (en) | Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid | |
WO2006138735A3 (en) | Gel compositions for topical administration | |
AU2003228442A1 (en) | Ophthalmic, pharmaceutical and other healthcare preparations with naturally occuring plant compounds, extracts and derivatives | |
WO2006118884A3 (en) | Drug delivery devices and related components, systems and methods | |
AU2002357972A1 (en) | Heparin-containing ophthalmic agent | |
AU2003297199A1 (en) | Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof | |
AU2002238855A1 (en) | N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same | |
PT1121127E (en) | PHARMACEUTICAL COMPOSITIONS ORAIS CONTAINING BUPRENORFIN | |
WO2001007049A3 (en) | Ophthalmic composition comprising ketotifen | |
WO2002067865A3 (en) | N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof | |
AU2001262011A1 (en) | A complex between folic acid and polysaccharides, its preparation method and a pharmaceutical composition comprising said complex as active component | |
AU2003224054A1 (en) | 4,5,6,7-tretrahydrobenzo(b) thiophene derivatives and methods for medical intervention against mycrobacterial infections | |
AU2003224482A1 (en) | Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same | |
AU2001230195A1 (en) | Pharmaceutical compositions comprising terbinafine | |
AU2001260110A1 (en) | Novel LHRH-antagonists, Production and Use Thereof as Medicament | |
WO2004048381A3 (en) | Pyrazoloazepine compounds as pharmaceutical agents | |
EP1411956B8 (en) | Use of oversulfated polysaccharides as inhibitors of hiv | |
AU2003232108A1 (en) | 1,1- and 1,2-bisphosphonates as apoliprotein e modulators | |
WO2002070537A3 (en) | Fusidic acid derivatives | |
HK1050203A1 (en) | Novel fusidic acid derivatives. | |
CA2366820A1 (en) | Novel [(2-substituted-5 -[3-thienyl) -benzyl]-[2- ([2-isopropoxy-5-fluoro] -phenoxy) -ethyl] -amine derivatives, method for the production and use thereof as medicaments | |
AU2003275360A1 (en) | Aqueous 2,6-diisopropylphenol pharmaceutical compositions | |
WO2001039725A3 (en) | Drug preparations | |
BRPI0410638A (en) | azithromycin derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LT LU LV MA MD MK MN MX NO NZ OM PH PL PT RO RU SE SG SI SK TJ TM TN TR TT UA US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002740697 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2449213 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003503256 Country of ref document: JP Ref document number: 028115317 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2002740697 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2002740697 Country of ref document: EP |